[Problems of therapy with adrenalin derivatives in pulmonary diseases].
D000403:Airway Resistance / Q000187:drug effects; D001249:Asthma / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy*; D002395:Catecholamines / Q000009:adverse effects; D004837:Epinephrine / Q000009:adverse effects*; D006801:Humans; D007545:Isoproterenol / Q000009:adverse effects; D009638:Norepinephrine / Q000009:adverse effects; D011656:Pulmonary Emphysema / Q000188:drug therapy*; D013610:Tachycardia / Q000139:chemically induced*; D014692:Ventilation-Perfusion Ratio / Q000187:drug effects
D002395:Catecholamines; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine
Proleme der Therapi e mit Adrenalin-Abkömmlingen bei pulmonalen Erkrankungen.